Literature DB >> 31053567

Focal therapy for localized prostate cancer: Where do we stand?

Bruno Nahar1, Dipen J Parekh2.   

Abstract

Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 31053567     DOI： 10.1016/j.euf.2019.04.012

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN： 2405-4569


  3 in total

1.  Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019.

Authors:  Luka Flegar; Aristeidis Zacharis; Cem Aksoy; Hendrik Heers; Marcus Derigs; Nicole Eisenmenger; Angelika Borkowetz; Christer Groeben; Johannes Huber
Journal:  World J Urol       Date:  2022-05-13       Impact factor: 3.661

2.  Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition.

Authors:  Armando Stabile; Marco Moschini; Francesco Montorsi; Xavier Cathelineau; Rafael Sanchez-Salas
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

3.  Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.

Authors:  Jost von Hardenberg; Hannes Cash; Daniel Koch; Angelika Borkowetz; Johannes Bruendl; Sami-Ramzi Leyh-Bannurah; Timur H Kuru; Karl-Friedrich Kowalewski; Daniel Schindele; Katharina S Mala; Niklas Westhoff; Andreas Blana; Martin Schostak
Journal:  World J Urol       Date:  2021-04-21       Impact factor: 4.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.